Comparison on the Anti-Diabetic Effect of NIKU Plus Versus Madhumega chooranam

Authors

  • Soundharya R.
  • Aruna V.
  • Amruthavalli G.V.
  • Gayathri R.

Abstract

The path breaking revolutionary proprietary Siddha drug NIKU plus was evaluated for the anti-diabetic activity and was compared with madhumegachooranam. The study findings clearly showed that NIKU is superior over madhumegachooranam. The careful integration of Siddha wisdom and modern science is attributed for the superior efficacy of NIKU plus over madhumegachooranam. The present study does not suggest the inferior efficacy of madhumegachooranam but highlights NIKU plus to be an improved version of a siddha formulation. Details are given in the study.

 

Keywords: Madumegachooranam, Nilavembu, NIKU, diabetic drug

Cite this Article

Soundharya R., Aruna V., Amruthavalli G.V., Gayathri R. Comparison on the Anti-diabetic effect of NIKU plus versus Madhumega chooranam. Research & Reviews: A Journal of Unani, Siddha and Homeopathy. 2019; 6(2): 24–28p.

Downloads

Published

2019-07-19

Issue

Vol. 6 No. 2 (2019)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.